` ANGO (AngioDynamics Inc) vs S&P 500 Comparison - Alpha Spread

ANGO
vs
S&P 500

Over the past 12 months, ANGO has significantly outperformed S&P 500, delivering a return of 69% compared to the S&P 500's 6% growth.

Stocks Performance
ANGO vs S&P 500

Loading
ANGO
S&P 500
Add Stock

Performance Gap
ANGO vs S&P 500

Loading
ANGO
S&P 500
Difference

Performance By Year
ANGO vs S&P 500

Loading
ANGO
S&P 500
Add Stock

Competitors Performance
AngioDynamics Inc vs Peers

AngioDynamics Inc
Glance View

Market Cap
401.4m USD
Industry
Health Care

AngioDynamics, Inc. is a medical device company, which engages in the development, manufacture, and sale of medical devices for vascular access, surgery, peripheral vascular disease, and oncology. The company is headquartered in Latham, New York and currently employs 800 full-time employees. The company went IPO on 2004-05-27. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

ANGO Intrinsic Value
5.86 USD
Overvaluation 40%
Intrinsic Value
Price
Back to Top